[144] Teradyne, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Teradyne, Inc. (TER): The filer reports an intended sale of 625 common shares through Fidelity Brokerage Services on 09/05/2025 with an aggregate market value of $75,037.50. The securities were acquired by restricted stock vesting on 05/09/2024 and were received as compensation. The filing also discloses prior sales by the same person this year: 1,875 shares sold 07/30/2025 for $198,243.75 and 625 shares sold 08/05/2025 for $66,250.00. The filing states the seller represents there is no undisclosed material adverse information. The total shares outstanding reported are 159,073,532 and the planned sale is on NASDAQ.

Positive

• Clear compliance with Rule 144 reporting requirements including acquisition details and broker information
• Source of shares disclosed (restricted stock vesting) and sale execution channel specified (Fidelity Brokerage Services)

Negative

• Insider sales reported recently totaling 2,500 shares in the past two months, which may warrant monitoring for patterns
• Issuer name and some filer contact fields are blank in the provided tables, limiting contextual detail in the filing text

Insights

Financial Analyst

TL;DR Insider sale notice: small planned sale relative to shares outstanding; recent prior sales reported.

The Form 144 indicates routine disposition of equity awarded via restricted stock vesting. The planned 625-share sale valued at $75,037.50 is immaterial relative to the reported 159 million shares outstanding, suggesting limited direct impact on Teradyne's capitalization or market supply. Recent prior sales totaling 2,500 shares and proceeds disclosed provide context on ongoing insider liquidity. This filing is primarily a compliance disclosure rather than a material corporate event.

Corporate Governance Expert

TL;DR Filing shows compliance with Rule 144 and disclosure of recent insider dispositions; no governance red flags in this notice alone.

The notice documents the source of shares (restricted stock vesting) and that sales are to be executed through an established broker, which aligns with standard insider sale procedures. The seller's representation about absence of undisclosed adverse information is standard. Without additional disclosures about issuer-specific events or larger-scale insider selling, this filing does not by itself raise governance concerns, though investors may track cumulative insider sales over time for pattern analysis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	625	75037.50	159073532	09/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2024	Restricted Stock Vesting	Issuer			625	05/09/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mercedes Johnson 600 Riverpark Drive North Reading MA 01864	Common	07/30/2025	1875	198243.75
Mercedes Johnson 600 Riverpark Drive North Reading MA 01864	Common	08/05/2025	625	66250.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TER Form 144 disclose about the planned sale?

The notice reports an intended sale of 625 common shares via Fidelity on 09/05/2025 with an aggregate market value of $75,037.50.

How were the 625 shares acquired according to the filing?

The shares were acquired on 05/09/2024 through restricted stock vesting and received as compensation.

What insider sales in the past three months does the filing report?

The filing lists sales of 1,875 shares on 07/30/2025 for $198,243.75 and 625 shares on 08/05/2025 for $66,250.00.

On which exchange will the planned sale occur?

The planned sale is reported to occur on NASDAQ through Fidelity Brokerage Services.

How large is the planned sale relative to Teradyne's outstanding shares?

The filing reports 159,073,532 shares outstanding; the planned 625-share sale is immaterial in scale relative to that total.